Applied Therapeutics (APLT) Current Leases (2023 - 2025)
Historic Current Leases for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $467000.0.
- Applied Therapeutics' Current Leases rose 7689.39% to $467000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $467000.0, marking a year-over-year increase of 7689.39%. This contributed to the annual value of $406000.0 for FY2024, which is 536.13% down from last year.
- Applied Therapeutics' Current Leases amounted to $467000.0 in Q3 2025, which was up 7689.39% from $447000.0 recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' Current Leases ranged from a high of $491000.0 in Q3 2023 and a low of $185000.0 during Q2 2024
- Moreover, its 3-year median value for Current Leases was $429000.0 (2023), whereas its average is $399272.7.
- Per our database at Business Quant, Applied Therapeutics' Current Leases plummeted by 6193.42% in 2024 and then skyrocketed by 14162.16% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Current Leases stood at $429000.0 in 2023, then decreased by 5.36% to $406000.0 in 2024, then grew by 15.02% to $467000.0 in 2025.
- Its last three reported values are $467000.0 in Q3 2025, $447000.0 for Q2 2025, and $426000.0 during Q1 2025.